Role of vitamin D in the prevention of pancreatic cancer

Journal of Nutrition and Metabolism

Volumn 2010, Issue , 2010, Pages

  Bulathsinghala, Pubudu ^a   Syrigos, Kostas N ^b   Saif, Muhammad W ^c  

^a DANBURY HOSPITAL   (United States)

^b SOTIRIA GENERAL HOSPITAL   (Greece)

^c Milstein Hospital ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 83455200647     PISSN: 20900724     EISSN: 20900732     Source Type: Journal    
DOI: 10.1155/2010/721365     Document Type: Review

References (120)

1. Soto J. L., Barbera V. M., Saceda M., Carrato A., Molecular biology of exocrine pancreatic cancer. Clinical and Translational Oncology 2006 8 5 306 312 2-s2.0-33747503956 10.1007/s12094-006-0175-9
2. Vulfovich M., Rocha-Lima C., Novel advances in pancreatic cancer treatment. Expert Review of Anticancer Therapy 2008 8 6 993 1002 2-s2.0-47249118032 10.1586/14737140.8.6.993
3. Berrington De González A., Spencer E. A., Bueno-De-Mesquita H. B., Roddam A., Stolzenberg-Solomon R., Halkjær J., Tjønneland A., Overvad K., Clavel-Chapelon F., Boutron-Ruault M. C., Boeing H., Pischon T., Linseisen J., Rohrmann S., Trichopoulou A., Benetou V., Papadimitriou A., Pala V., Palli D., Panico S., Tumino R., Vineis P., Boshuizen H. C., Ocke M. C., Peeters P. H., Lund E., Gonzalez C. A., Larrañaga N., Martinez-Garcia C., Mendez M., Navarro C., Quirós J. R., Tormo M. J., Hallmans G., Ye W., Bingham S. A., Khaw K. T., Allen N., Key T. J., Jenab M., Norat T., Ferrari P., Riboli E., Anthropometry, physical activity, and the risk of pancreatic cancer in the European Prospective Investigation into Cancer and Nutrition. Cancer Epidemiology Biomarkers and Prevention 2006 15 5 879 885 2-s2.0-33744722474 10.1158/1055-9965.EPI-05-0800 (Pubitemid 43823512)
4. Patel A. V., Rodriguez C., Bernstein L., Chao A., Thun M. J., Calle E. E., Obesity, recreational physical activity, and risk of pancreatic cancer in a large U.S. cohort. Cancer Epidemiology Biomarkers and Prevention 2005 14 2 459 466 2-s2.0-13944264682 10.1158/1055-9965.EPI-04-0583 (Pubitemid 40270112)
5. Luo J., Iwasaki M., Inoue M., Sasazuki S., Otani T., Ye W., Tsugane S., Body mass index, physical activity and the risk of pancreatic cancer in relation to smoking status and history of diabetes: a large-scale population-based cohort study in Japan-the JPHC study. Cancer Causes and Control 2007 18 6 603 612 2-s2.0-34250020413 10.1007/s10552-007-9002-z (Pubitemid 46883677)
6. Raimondi S., Maisonneuve P., Lowenfels A. B., Epidemiology of pancreatic cancer: an overview. Nature Reviews Gastroenterology and Hepatology 2009 6 12 699 708 2-s2.0-74949144690 10.1038/nrgastro.2009.177
7. Chan J. M., Wang F., Holly E. A., Sweets, sweetened beverages, and risk of pancreatic cancer in a large population-based case-control study. Cancer Causes and Control 2009 20 6 835 846 2-s2.0-68849122232 10.1007/s10552-009-9323- 1
8. Moore M. J., Goldstein D., Hamm J., Figer A., Hecht J. R., Gallinger S., Au H. J., Murawa P., Walde D., Wolff R. A., Campos D., Lim R., Ding K., Clark G., Voskoglou-Nomikos T., Ptasynski M., Parulekar W., Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group. Journal of Clinical Oncology 2007 25 15 1960 1966 2-s2.0-34249933404 10.1200/JCO.2006.07.9525 (Pubitemid 46972777)
9. Ahlgren J. D., Chemotherapy for pancreatic carcinoma. Cancer 1996 78 3 654 663 2-s2.0-0030015038 10.1002/(SICI)1097-0142(19960801)78:3<654::AID- CNCR46>3.0.CO;2-V (Pubitemid 26251525)
10. Cullinan S. A., Moertel C. G., Fleming T. R., A comparison of three chemotherapeutic regimens in the treatment of advanced pancreatic and gastric carcinoma. Fluorouracil vs fluorouracil and doxorubicin vs fluorouracil, doxorubicin, and mitomycin. Journal of the American Medical Association 1985 253 14 2061 2067 2-s2.0-0021963054 10.1001/jama.253.14.2061 (Pubitemid 15102220)
11. Ducreux M., Rougier P., Pignon J. P., Adenis A., Berthault-Cvitkovic F., Douillard J. Y., Luboinski M., Seitz J. F., Bugat R., Ychou M., Bosset J. F., Merouche Y., Raoul J. L., A randomised trial comparing 5-FU with 5-FU plus cisplatin in advanced pancreatic carcinoma. Annals of Oncology 2002 13 8 1185 1191 2-s2.0-0036668658 10.1093/annonc/mdf197 (Pubitemid 34960125)
12. Klinkenbijl J. H., Jeekel J., Sahmoud T., Van Pel R., Couvreur M. L., Veenhof C. H., Arnaud J. P., Gonzalez D. G., De Wit L. T., Hennipman A., Wils J., Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC Gastrointestinal Tract Cancer Cooperative Group. Annals of Surgery 1999 230 6 776 784 2-s2.0-0033497862 10.1097/00000658-199912000-00006 (Pubitemid 30191812)
13. Slebos R. J. C., Hoppin J. A., Tolbert P. E., Holly E. A., Brock J. W., Zhang R. H., Bracci P. M., Foley J., Stockton P., McGregor L. M., Flake G. P., Taylor J. A., K-ras and p53 in pancreatic cancer: association with medical history, histopathology, and environmental exposures in a population-based study. Cancer Epidemiology Biomarkers and Prevention 2000 9 11 1223 1232 2-s2.0-0033729483
14. Fleming J. B., Shen G. L., Holloway S. E., Davis M., Brekken R. A., Molecular consequences of silencing mutant K-ras in pancreatic cancer cells: justification for K-ras-directed therapy. Molecular Cancer Research 2005 3 7 413 423 2-s2.0-22944447177 10.1158/1541-7786.MCR-04-0206 (Pubitemid 41045591)
15. Wei M. Y., Garland C. F., Gorham E. D., Mohr S. B., Giovannucci E., Vitamin D and prevention of colorectal adenoma: a meta-analysis. Cancer Epidemiology Biomarkers and Prevention 2008 17 11 2958 2969 2-s2.0-55849124377 10.1158/1055-9965.EPI-08-0402
16. Garland C. F., Gorham E. D., Mohr S. B., Grant W. B., Giovannucci E. L., Lipkin M., Newmark H., Holick M. F., Garland F. C., Vitamin D and prevention of breast cancer: pooled analysis. Journal of Steroid Biochemistry and Molecular Biology 2007 103 3-5 708 711 2-s2.0-33947275797 10.1016/j.jsbmb.2006.12.007 (Pubitemid 46420519)
17. Garland C. F., Mohr S. B., Gorham E. D., Grant W. B., Garland F. C., Role of ultraviolet B irradiance and vitamin D in prevention of ovarian cancer. American Journal of Preventive Medicine 2006 31 6 512 514 2-s2.0-33845336119 10.1016/j.amepre.2006.08.018 (Pubitemid 44880583)
18. Grant W. B., wbgrant@infionline.net Relation between prediagnostic serum 25-hydroxyvitamin D level and incidence of breast, colorectal, and other cancers. Journal of Photochemistry and Photobiology B 2010 101 2 130 136 10.1016/j.jphotobiol.2010.04.008
19. Garland C. F., Gorham E. D., Mohr S. B., Garland F. C., Vitamin D for cancer prevention: global perspective. Annals of Epidemiology 2009 19 7 468 483 2-s2.0-66449083031 10.1016/j.annepidem.2009.03.021
20. Holick M. F., Resurrection of vitamin D deficiency and rickets. Journal of Clinical Investigation 2006 116 8 2062 2072 2-s2.0-33746741731 10.1172/JCI29449 (Pubitemid 44162310)
21. DeLuca H. F., Overview of general physiologic features and functions of vitamin D. The American journal of clinical nutrition 2004 80 6 1689S 1696S 2-s2.0-16244418604
22. Luscombe C. J., Fryer A. A., French M. E., Liu S., Saxby M. F., Jones P. W., Strange R. C., Exposure to ultraviolet radiation: association with susceptibility and age at presentation with prostate cancer. Lancet 2001 358 9282 641 642 2-s2.0-0035949122 10.1016/S0140-6736(01)05788-9 (Pubitemid 32786834)
23. John E. M., Koo J., Schwartz G. G., Sun exposure and prostate cancer risk: evidence for a protective effect of early-life exposure. Cancer Epidemiology Biomarkers and Prevention 2007 16 6 1283 1286 2-s2.0-34250851807 10.1158/1055-9965.EPI-06-1053 (Pubitemid 46984972)
24. De Vries E., Soerjomataram I., Houterman S., Louwman M. W. J., Coebergh J. W. W., Decreased risk of prostate cancer after skin cancer diagnosis: a protective role of ultraviolet radiation? American Journal of Epidemiology 2007 165 8 966 972 2-s2.0-34047214072 10.1093/aje/kwk084 (Pubitemid 46536663)
25. Holick M. F., Tian X. Q., Allen M., Evolutionary importance for the membrane enhancement of the production of vitamin D in the skin of poikilothermic animals. Proceedings of the National Academy of Sciences of the United States of America 1995 92 8 3124 3126 2-s2.0-0028938524
26. Mohr S. B., Garland C. F., cgarland@ucsd.edu Gorham E. D., Grant W. B., Garland F. C., Ultraviolet b irradiance and vitamin d status are inversely associated with incidence rates of pancreatic cancer worldwide. Pancreas 2010 39 5 669 674 10.1097/MPA.0b013e3181ce654d
27. Grant W. B., Garland C. F., The association of solar ultraviolet B (UVB) with reducing risk of cancer: multifactorial ecologic analysis of geographic variation in age-adjusted cancer mortality rates. Anticancer Research 2006 26 4A 2687 2699 2-s2.0-33644815537 (Pubitemid 44155550)
28. Boscoe F. P., Schymura M. J., Solar ultraviolet-B exposure and cancer incidence and mortality in the United States, 1993-2002. BMC Cancer 2006 6, article no. 264 2-s2.0-33845204374 10.1186/1471-2407-6-264 (Pubitemid 44848507)
29. Giovannucci E., Liu Y., Rimm E. B., Hollis B. W., Fuchs C. S., Stampfer M. J., Willett W. C., Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. Journal of the National Cancer Institute 2006 98 7 451 459 2-s2.0-33645740073 10.1093/jnci/djj101
30. Grant W. B., An estimate of premature cancer mortality in the U.S. due to inadequate doses of solar ultraviolet-B radiation. Cancer 2002 94 6 1867 1875 2-s2.0-0037086547 10.1002/cncr.10427 (Pubitemid 34241126)
31. Grant W. B., Ecologic studies of solar UV-B radiation and cancer mortality rates. Recent Results in Cancer Research 2003 164 371 377 2-s2.0-0642367252
32. Kinoshita S., Wagatsuma Y., Okada M., Geographical distribution for malignant neoplasm of the pancreas in relation to selected climatic factors in Japan. International Journal of Health Geographics 2007 6, article no. 34 2-s2.0-34548546615 10.1186/1476-072X-6-34
33. Mizoue T., Ecological study of solar radiation and cancer mortality in Japan. Health Physics 2004 87 5 532 538 2-s2.0-14844285407 10.1097/01.HP. 0000137179.03423.0b (Pubitemid 40340625)
34. Mohr S. B., A brief history of vitamin d and cancer prevention. Annals of Epidemiology 2009 19 2 79 83 2-s2.0-58649112823 10.1016/j.annepidem.2008.10.003
35. Fernandez E., La Vecchia C., D'Avanzo B., Negri E., Menstrual and reproductive factors and pancreatic cancer risk in women. International Journal of Cancer 1995 62 1 11 14 2-s2.0-0029046074 10.1002/ijc.2910620104
36. Grant W. B., How strong is the evidence that solar ultraviolet B and vitamin D reduce the risk of cancer?: an examination using Hill's criteria for causality. Dermatoendocrinol 2009 1 1 17 24
37. Grant W. B., Boucher B. J., Current impediments to acceptance of the ultraviolet-B-vitamin D-cancer hypothesis. Anticancer Research 2009 29 9 3597 3604 2-s2.0-68549135083
38. Holick M. F., Vitamin D: a millenium perspective. Journal of Cellular Biochemistry 2003 88 2 296 307 2-s2.0-0037302906 10.1002/jcb.10338 (Pubitemid 36119902)
39. Grant W. B., Strange R. C., Garland C. F., Sunshine is good medicine. The health benefits of ultraviolet-B induced vitamin D production. Journal of Cosmetic Dermatology 2003 2 2 86 98
40. Holick M. F., Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. American Journal of Clinical Nutrition 2004 79 3 362 371 2-s2.0-1642281100 (Pubitemid 41115577)
41. Grant W. B., Vitamin D and racial disparities for pancreatic cancer-letter. Cancer Epidemiology Biomarkers and Prevention 2010 19 3 888 2-s2.0-77949681023 10.1158/1055-9965.EPI-09-0897
42. Giovannucci E., Vitamin D and cancer incidence in the Harvard cohorts. Annals of Epidemiology 2009 19 2 84 88 2-s2.0-58949095024 10.1016/j.annepidem. 2007.12.002
43. Arabi A., El Rassi R., El-Hajj Fuleihan G., gf01@aub.edu.lb Hypovitaminosis D in developing countries-prevalence, risk factors and outcomes. Nature Reviews Endocrinology 2010 6 10 550 561 10.1038/nrendo.2010.146
44. Neale R. E., Youlden D. R., Krnjacki L., Kimlin M. G., Van Der Pols J. C., Latitude variation in pancreatic cancer mortality in Australia. Pancreas 2009 38 4 387 390 2-s2.0-66149132272 10.1097/MPA.0b013e31819975f4
45. Holick M. F., Medical progress: vitamin D deficiency. New England Journal of Medicine 2007 357 3 266 281 2-s2.0-34447514029 10.1056/NEJMra070553 (Pubitemid 47080391)
46. Holick M. F., McCollum award lecture, 1994: vitamin D-new horizons for the 21st century. American Journal of Clinical Nutrition 1994 60 4 619 630 2-s2.0-0028097038
47. Clemens T. L., Adams J. S., Henderson S. L., Holick M. F., Increased skin pigment reduces the capacity of skin to synthesise vitamin D. Lancet 1982 1 8263 74 76 2-s2.0-0020040970 (Pubitemid 12248649)
48. Webb A. R., Kline L., Holick M. F., Influence of season and latitude on the cutaneous synthesis of vitamin D: exposure to winter sunlight in Boston and Edmonton will not promote vitamin D synthesis in human skin. Journal of Clinical Endocrinology and Metabolism 1988 67 2 373 378 2-s2.0-0023741187
49. Armas L. A. G., Hollis B. W., Heaney R. P., Vitamin D is much less effective than vitamin D in humans. Journal of Clinical Endocrinology and Metabolism 2004 89 11 5387 5391 2-s2.0-8744276604 10.1210/jc.2004-0360 (Pubitemid 39518413)
50. Holick M. F., Biancuzzo R. M., Chen T. C., Klein E. K., Young A., Bibuld D., Reitz R., Salameh W., Ameri A., Tannenbaum A. D., Vitamin D is as effective as vitamin D in maintaining circulating concentrations of 25-hydroxyvitamin D. Journal of Clinical Endocrinology and Metabolism 2008 93 3 677 681 2-s2.0-40849085157 10.1210/jc.2007-2308 (Pubitemid 351398538)
51. Stumpf W. E., Sar M., Reid F. A., Target cells for 1,25-dihydroxyvitamin D in intestinal tract, stomach, kidney, skin, pituitary, and parathyroid. Science 1979 206 4423 1188 1190 2-s2.0-0018578621 (Pubitemid 10159658)
52. Schwalfenberg G., Not enough vitamin D: health consequences for Canadians. Canadian Family Physician 2007 53 5 841 854 2-s2.0-34547489982 (Pubitemid 47164277)
53. Cross H. S., Commentary: from epidemiology to molecular biology-vitamin D and colorectal cancer prevention. International Journal of Epidemiology 2006 35 2 225 227 2-s2.0-33645811285 10.1093/ije/dyi233
54. Giovannucci E., The epidemiology of vitamin D and cancer incidence and mortality: a review (United States). Cancer Causes and Control 2005 16 2 83 95 2-s2.0-18844409137 10.1007/s10552-004-1661-4 (Pubitemid 40691207)
55. Giovannucci E., The epidemiology of vitamin D and colorectal cancer: recent findings. Current Opinion in Gastroenterology 2006 22 1 24 29 2-s2.0-33644805351 10.1097/01.mog.0000196150.36701.c2 (Pubitemid 44124279)
56. Grant W. B., Holick M. F., Benefits and requirements of vitamin D for optimal health: a review. Alternative Medicine Review 2005 10 2 94 111 2-s2.0-21344463548 (Pubitemid 40911119)
57. Shin M. H., Holmes M. D., Hankinson S. E., Wu K., Colditz G. A., Willett W. C., Intake of dairy products, calcium, and vitamin D and risk of breast cancer. Journal of the National Cancer Institute 2002 94 17 1301 1311 2-s2.0-0037019749
58. Lin J., Manson J. E., Lee I. M., Cook N. R., Buring J. E., Zhang S. M., Intakes of calcium and vitamin D and breast cancer risk in women. Archives of Internal Medicine 2007 167 10 1050 1059 2-s2.0-34249655770 10.1001/archinte.167. 10.1050 (Pubitemid 46835793)
59. Bérubé S., Diorio C., Mâsse B., Hébert-Croteau N., Byrne C., Côté G., Pollak M., Yaffe M., Brisson J., Vitamin D and calcium intakes from food or supplements and mammographic breast density. Cancer Epidemiology Biomarkers and Prevention 2005 14 7 1653 1659 2-s2.0-22244486295 10.1158/1055-9965.EPI-05-0068 (Pubitemid 40995075)
60. Bertone-Johnson E. R., Chen W. Y., Holick M. F., Hollis B. W., Colditz G. A., Willett W. C., Hankinson S. E., Plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D and risk of breast cancer. Cancer Epidemiology Biomarkers and Prevention 2005 14 8 1991 1997 2-s2.0-23844499356 10.1158/1055-9965.EPI-04-0722 (Pubitemid 41161213)
61. Porojnicu A. C., Lagunova Z., Robsahm T. E., Berg J. P., Dahlback A., Moan J., Changes in risk of death from breast cancer with season and latitude: sun exposure and breast cancer survival in Norway. Breast Cancer Research and Treatment 2007 102 3 323 328 2-s2.0-33947529443 10.1007/s10549-006-9331-8 (Pubitemid 46474836)
62. Grant W. B., An ecologic study of cancer mortality rates in Spain with respect to indices of solar UVB irradiance and smoking. International Journal of Cancer 2007 120 5 1123 1128 2-s2.0-33846827035 10.1002/ijc.22386 (Pubitemid 46214316)
63. Skinner H. G., Michaud D. S., Giovannucci E., Willett W. C., Colditz G. A., Fuchs C. S., Vitamin D intake and the risk for pancreatic cancer in two cohort studies. Cancer Epidemiology Biomarkers and Prevention 2006 15 9 1688 1695 2-s2.0-33749368383 10.1158/1055-9965.EPI-06-0206 (Pubitemid 44497105)
64. Chung I., Yu W. D., Karpf A. R., Flynn G., Bernardi R. J., Modzelewski R. A., Johnson C. S., Trump D. L., Anti-proliferative effects of calcitriol on endothelial cells derived from two different microenvironments. Journal of Steroid Biochemistry and Molecular Biology 2007 103 3-5 768 770 2-s2.0-33947108955 10.1016/j.jsbmb.2006.12.042 (Pubitemid 46401333)
65. Flynn G., Chung I., Yu W. D., Romano M., Modzelewski R. A., Johnson C. S., Trump D. L., Calcitriol (1,25-dihydroxycholecalciferol) selectively inhibits proliferation of freshly isolated tumor-derived endothelial cells and induces apoptosis. Oncology 2007 70 6 447 457 2-s2.0-33847390758 10.1159/000098872 (Pubitemid 46333766)
66. Deeb K. K., Trump D. L., Johnson C. S., Vitamin D signalling pathways in cancer: potential for anticancer therapeutics. Nature Reviews Cancer 2007 7 9 684 700 2-s2.0-34548202165 10.1038/nrc2196 (Pubitemid 47327412)
67. Gorham E. D., Garland C. F., Garland F. C., Grant W. B., Mohr S. B., Lipkin M., Newmark H. L., Giovannucci E., Wei M., Holick M. F., Optimal vitamin D status for colorectal cancer prevention: a quantitative meta analysis. American Journal of Preventive Medicine 2007 32 3 210 216 2-s2.0-33846889776 10.1016/j.amepre.2006.11.004 (Pubitemid 46223622)
68. Lappe J. M., Travers-Gustafson D., Davies K. M., Recker R. R., Heaney R. P., Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. American Journal of Clinical Nutrition 2007 85 6 1586 1591 2-s2.0-34250015299 (Pubitemid 46890428)
69. Pendás-Franco N., González-Sancho J. M., Suárez Y., Aguilera O., Steinmeyer A., Gamallo C., Berciano M. T., Lafarga M., Muñoz A., Vitamin D regulates the phenotype of human breast cancer cells. Differentiation 2007 75 3 193 207 2-s2.0-33947221529 10.1111/j.1432-0436.2006. 00131.x (Pubitemid 46426618)
70. Zheng YU., Zhou H., Modzelewski J. R. K., Kalak R., Blair J. M., Seibel M. J., Dunstan C. R., Accelerated bone resorption, due to dietary calcium deficiency, promotes breast cancer tumor growth in bone. Cancer Research 2007 67 19 9542 9548 2-s2.0-35148814409 10.1158/0008-5472.CAN-07-1046 (Pubitemid 47535945)
71. Grant W. B., Cross H. S., Garland C. F., Gorham E. D., Moan J., Peterlik M., Porojnicu A. C., Reichrath J., Zittermann A., Estimated benefit of increased vitamin D status in reducing the economic burden of disease in western Europe. Progress in Biophysics and Molecular Biology 2009 99 2-3 104 113 2-s2.0-68549138585 10.1016/j.pbiomolbio.2009.02.003
72. Grant W. B., wbgrant@infionline.net Schwalfenberg G. K., Genuis S. J., Whiting S. J., An estimate of the economic burden and premature deaths due to vitamin D deficiency in Canada. Molecular Nutrition and Food Research 2010 54 8 1172 1181 10.1002/mnfr.200900420
73. Garland C. F., Grant W. B., Mohr S. B., Gorham E. D., Garland F. C., What is the dose-response relationship between vitamin D and cancer risk? Nutrition Reviews 2007 65 8 S91 S95 2-s2.0-35148872638
74. Chiang K. C., Chen T. C., Vitamin D for the prevention and treatment of pancreatic cancer. World Journal of Gastroenterology 2009 15 27 3349 3354 2-s2.0-70349578361 10.3748/wjg.15.3349
75. Block K. I., Koch A. C., Mead M. N., Tothy P. K., Newman R. A., Gyllenhaal C., Impact of antioxidant supplementation on chemotherapeutic efficacy: a systematic review of the evidence from randomized controlled trials. Cancer Treatment Reviews 2007 33 5 407 418 2-s2.0-34547197625 10.1016/j.ctrv.2007.01.005 (Pubitemid 47324224)
76. Trouillas P., Honnorat J., Bret P., Jouvet A., Gerard J. P., Redifferentiation therapy in brain tumors: long-lasting complete regression of glioblastomas and an anaplastic astrocytoma under long term 1-alpha- hydroxycholecalciferol. Journal of Neuro-Oncology 2001 51 1 57 66 2-s2.0-0035048703 10.1023/A:1006437003352 (Pubitemid 32321903)
77. Woo T. C.S., Choo R., choo.c@mayo.edu Jamieson M., Chander S., Vieth R., Pilot study: potential role of vitamin D (cholecalciferol) in patients with PSA relapse after definitive therapy. Nutrition and Cancer 2005 51 1 32 36 10.1207/s15327914nc5101-5 (Pubitemid 40365979)
78. Gross C., Stamey T., Hancock S., Feldman D., Treatment of early recurrent prostate cancer with 1,25-dihydroxyvitamin D3 (calcitriol). Journal of Urology 1998 159 6 2035 2040 2-s2.0-0032439651 (Pubitemid 29190750)
79. Blanke C. D., Beer T. M., Todd K., Mori M., Stone M., Lopez C., Phase II study of calcitriol-enhanced docetaxel in patients with previously untreated metastatic or locally advanced pancreatic cancer. Investigational New Drugs 2009 27 4 374 378 2-s2.0-67651156227 10.1007/s10637-008-9184-6
80. Krishnan A. V., Moreno J., Nonn L., Malloy P., Swami S., Peng L., Peehl D. M., Feldman D., Novel pathways that contribute to the anti-proliferative and chemopreventive activities of calcitriol in prostate cancer. Journal of Steroid Biochemistry and Molecular Biology 2007 103 3-5 694 702 2-s2.0-33947176624 10.1016/j.jsbmb.2006.12.051 (Pubitemid 46401340)
81. Moreno J., Krishnan A. V., Feldman D., Molecular mechanisms mediating the anti-proliferative effects of Vitamin D in prostate cancer. Journal of Steroid Biochemistry and Molecular Biology 2005 97 1-2 31 36 2-s2.0-27544449930 10.1016/j.jsbmb.2005.06.012 (Pubitemid 41546211)
82. Bikle D. D., Vitamin D regulated keratinocyte differentiation. Journal of Cellular Biochemistry 2004 92 3 436 444 2-s2.0-12344300880 10.1002/jcb.20095
83. Chen T. C., Holick M. F., Vitamin D and prostate cancer prevention and treatment. Trends in Endocrinology and Metabolism 2003 14 9 423 430 2-s2.0-0242612058 10.1016/j.tem.2003.09.004 (Pubitemid 37392215)
84. Demay M. B., Mechanism of vitamin D receptor action. Annals of the New York Academy of Sciences 2006 1068 1 204 213 2-s2.0-33744769686 10.1196/annals.1346.026 (Pubitemid 43824151)
85. Zhang Y., Zhang J., Studzinski G. P., AKT pathway is activated by 1,25-dihydroxyvitamin D and participates in its anti-apoptotic effect and cell cycle control in differentiating HL60 cells. Cell Cycle 2006 5 4 447 451 2-s2.0-33645211141
86. 2: mitochondria as a convergence point in the death pathway. Free Radical Biology and Medicine 2005 39 2 266 278 2-s2.0-20444479080 10.1016/j.freeradbiomed.2005.03.018 (Pubitemid 40814552)
87. Mathieu C., Adorini L., The coming of age of 1,25-dihydroxyvitamin D analogs as immunomodulatory agents. Trends in Molecular Medicine 2002 8 4 174 179 2-s2.0-0036220629 10.1016/S1471-4914(02)02294-3 (Pubitemid 34297090)
88. Ingraham B. A., Bragdon B., Nohe A., Molecular basis of the potential of vitamin D to prevent cancer. Current Medical Research and Opinion 2008 24 1 139 149 2-s2.0-38549125522 10.1185/030079907X253519 (Pubitemid 351160247)
89. Guyton K. Z., Kensler T. W., Posner G. H., Vitamin D and vitamin D analogs as cancer chemopreventive agents. Nutrition Reviews 2003 61 7 227 238 2-s2.0-0041734672 10.1301/nr.2003.jul.227-238 (Pubitemid 37259932)
90. Huang Y. C., Chen J. Y., Hung W. C., Vitamin D receptor/Sp1 complex is required for the induction of p27 expression by vitamin D. Oncogene 2004 23 28 4856 4861 2-s2.0-3042728575 10.1038/sj.onc.1207621 (Pubitemid 38932158)
91. Campbell M. J., Gombart A. F., Kwok S. H., Park S., Koeffler H. P., The anti-proliferative effects of 1 α25(OH)D on breast and prostate cancer cells are associated with induction of BRCA1 gene expression. Oncogene 2000 19 44 5091 5097 2-s2.0-0034687341
92. Maruyama R., Aoki F., Toyota M., Sasaki Y., Akashi H., Mita H., Suzuki H., Akino K., Ohe-Toyota M., Maruyama Y., Tatsumi H., Imai K., Shinomura Y., Tokino T., Comparative genome analysis identifies the vitamin D receptor gene as a direct target of p53-mediated transcriptional activation. Cancer Research 2006 66 9 4574 4583 2-s2.0-33646403420 10.1158/0008-5472.CAN-05-2562
93. DeMasters G., Di XU., Newsham I., Shiu R., Gewirtz D. A., Potentiation of radiation sensitivity in breast tumor cells by the vitamin D analogue, EB 1089, through promotion of autophagy and interference with proliferative recovery. Molecular Cancer Therapeutics 2006 5 11 2786 2797 2-s2.0-33845192397 10.1158/1535-7163.MCT-06-0316 (Pubitemid 44849005)
94. Campbell F. C., Xu H., El-Tanani M., Crowe P., Bingham V., The Yin and Yang of vitamin D receptor (VDR) signaling in neoplastic progression: operational networks and tissue-specific growth control. Biochemical Pharmacology 2010 79 1 1 9 2-s2.0-70350211844 10.1016/j.bcp.2009.09.005
95. Rehder D. S., Nelson R. W., Borges C. R., Glycosylation status of vitamin D binding protein in cancer patients. Protein Science 2009 18 10 2036 2042 2-s2.0-70349473231 10.1002/pro.214
96. 3 Carcinogenesis 2004 25 6 1015 1026 2-s2.0-3042819559 10.1093/carcin/bgh086 (Pubitemid 38898637)
97. Pettersson F., Colston K. W., Dalgleish A. G., Differential and antagonistic effects of 9-cis-retinoic acid and vitamin D analogues on pancreatic cancer cells in vitro. British Journal of Cancer 2000 83 2 239 245 2-s2.0-0034049568 (Pubitemid 30411724)
98. Colston K. W., James S. Y., Ofori-Kuragu E. A., Binderup L., Grant A. G., Vitamin D receptors and anti-proliferative effects of vitamin D derivatives in human pancreatic carcinoma cells in vivo and in vitro. British Journal of Cancer 1997 76 8 1017 1020 2-s2.0-0030828301 (Pubitemid 27434657)
99. Gupta D., Lammersfeld C. A., Trukova K., Lis C. G., Vitamin D and prostate cancer risk: a review of the epidemiological literature. Prostate Cancer and Prostatic Diseases 2009 12 3 215 226 2-s2.0-70349106899 10.1038/pcan.2009.7
100. Ng K., Wolpin B. M., Meyerhardt J. A., Wu K., Chan A. T., Hollis B. W., Giovannucci E. L., Stampfer M. J., Willett W. C., Fuchs C. S., Prospective study of predictors of vitamin D status and survival in patients with colorectal cancer. British Journal of Cancer 2009 101 6 916 923 2-s2.0-70249107054 10.1038/sj.bjc.6605262
101. Ng A. C., Kumar S. K., Rajkumar S. V., Drake M. T., Impact of vitamin D deficiency on the clinical presentation and prognosis of patients with newly diagnosed multiple myeloma. American Journal of Hematology 2009 84 7 397 400 2-s2.0-67649697320 10.1002/ajh.21412
102. Drake M. T., Maurer M. J., Link B. K., Habermann T. M., Ansell S. M., Micallef I. N., Kelly J. L., Macon W. R., Nowakowski G. S., Inwards D. J., Johnston P. B., Singh R. J., Allmer C., Slager S. L., Weiner G. J., Witzig T. E., Cerhan J. R., Vitamin D insufficiency and prognosis in non-Hodgkin's lymphoma. Journal of Clinical Oncology 2010 28 27 4191 4198 10.1200/JCO.2010.28. 6674
103. Newton-Bishop J. A., Beswick S., Randerson-Moor J., Chang YU. M., Affleck P., Elliott F., Chan M., Leake S., Karpavicius B., Haynes S., Kukalizch K., Whitaker L., Jackson S., Gerry E., Nolan C., Bertram C., Marsden J., Elder D. E., Barrett J. H., Bishop D. T., Serum 25-hydroxyvitamin D levels are associated with Breslow thickness at presentation and survival from melanoma. Journal of Clinical Oncology 2009 27 32 5439 5444 2-s2.0-73949092448 10.1200/JCO.2009.22. 1135
104. Moan J., Dahlback A., Lagunova Z., Cicarma E., Porojnicu A. C., Solar radiation, vitamin D and cancer incidence and mortality in Norway. Anticancer Research 2009 29 9 3501 3509 2-s2.0-68549115321
105. Stolzenberg-Solomon R. Z., Pietinen P., Taylor P. R., Virtamo J., Albanes D., Prospective study of diet and pancreatic cancer in male smokers. American Journal of Epidemiology 2002 155 9 783 792 2-s2.0-0036569559 10.1093/aje/155.9.783 (Pubitemid 34456987)
106. Norman H. A., h.norman@aicr.org Go V. L.W., Butrum R. R., Review of the International Research Conference on Food, Nutrition, and Cancer, 2004. Journal of Nutrition 2004 134 supplement 12 3391S 3393S (Pubitemid 39587579)
107. Chung M., Balk E. M., Ip S., Lee J., Terasawa T., Raman G., Trikalinos T., Lichtenstein A. H., Lau J., Systematic review to support the development of nutrient reference intake values: challenges and solutions. The American journal of clinical nutrition 2010 92 2 273 276 10.3945/ajcn.2009.29092
108. Holick M. F., High prevalence of vitamin D inadequacy and implications for health. Mayo Clinic Proceedings 2006 81 3 353 373 2-s2.0-33644668623 10.4065/81.3.353 (Pubitemid 43334631)
109. Bischoff-Ferrari H. A., Giovannucci E., Willett W. C., Dietrich T., Dawson-Hughes B., Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. American Journal of Clinical Nutrition 2006 84 1 18 28 2-s2.0-33747400934 (Pubitemid 44699167)
110. Holick M. F., Siris E. S., Binkley N., Beard M. K., Khan A., Katzer J. T., Petruschke R. A., Chen E., De Papp A. E., Prevalence of vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy. Journal of Clinical Endocrinology and Metabolism 2005 90 6 3215 3224 2-s2.0-21244465557 10.1210/jc.2004-2364 (Pubitemid 41014278)
111. Dawson-Hughes B., Heaney R. P., Holick M. F., Lips P., Meunier P. J., Vieth R., Estimates of optimal vitamin D status. Osteoporosis International 2005 16 7 713 716 2-s2.0-20444362348 10.1007/s00198-005-1867-7 (Pubitemid 40933586)
112. Helzlsouer K. J., Overview of the cohort consortium vitamin d pooling project of rarer cancers. American Journal of Epidemiology 2010 172 1 4 9 10.1093/aje/kwq119
113. Bao Y., Ng K., Wolpin B. M., Michaud D. S., Giovannucci E., Fuchs C. S., Predicted vitamin D status and pancreatic cancer risk in two prospective cohort studies. British Journal of Cancer 2010 102 9 1422 1427 2-s2.0-77951667934 10.1038/sj.bjc.6605658
114. Stolzenberg-Solomon R. Z., Jacobs E. J., Arslan A. A., Circulating 25-hydroxyvitamin D and risk of pancreatic cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. American Journal of Epidemiology 2010 172 1 81 93
115. Stolzenberg-Solomon R. Z., Hayes R. B., Horst R. L., Anderson K. E., Hollis B. W., Silverman D. T., Serum vitamin D and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian screening trial. Cancer Research 2009 69 4 1439 1447 2-s2.0-60549102497 10.1158/0008-5472.CAN-08-2694
116. International Agency for Research on Cancer Working Group, Report 5: Vitamin D and Cancer 2008 Lyon, France IARC
117. Grant W. B., Critique of the U-shaped serum 25-hydroxyvitamin D level-disease response relation. Dermato-Endocrinology 2009 1 5 289 293
118. Ahn J., Albanes D., Berndt S. I., Peters U., Chatterjee N., Freedman N. D., Abnet C. C., Huang W. Y., Kibel A. S., Crawford D. E., Weinstein S. J., Chanock S. J., Schatzkin A., Hayes R. B., Vitamin D-related genes, serum vitamin D concentrations and prostate cancer risk. Carcinogenesis 2009 30 5 769 776 2-s2.0-65549109430 10.1093/carcin/bgp055
119. Heist R. S., Zhou W., Wang Z., Liu G., Neuberg D., Su LI., Asomaning K., Hollis B. W., Lynch T. J., Wain J. C., Giovannucci E., Christiani D. C., Circulating 25-hydroxyvitamin D, VDR polymorphisms, and survival in advanced non-small-cell lung cancer. Journal of Clinical Oncology 2008 26 34 5596 5602 2-s2.0-57149091360 10.1200/JCO.2008.18.0406
120. Petta S., Cammà C., Scazzone C., Tripodo C., Marco V. D., Bono A., Cabibi D., Licata G., Porcasi R., Marchesini G., Craxí A., Low vitamin d serum level is related to severe fibrosis and low responsiveness to interferon-based therapy in genotype 1 chronic hepatitis C. Hepatology 2010 51 4 1158 1167 2-s2.0-77950624679 10.1002/hep.23489